5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents

被引：69

作者：

Nilsson, Bjorn M. ^{[1
]}

机构：

[1] Biovitrum AG, SE-11276 Stockholm, Sweden

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 14期

关键词：

D O I：

10.1021/jm058240i

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：4023 / 4034

页数：12

共 130 条

[1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension [J].

Abenhaim, L ;

Moride, Y ;

Brenot, F ;

Rich, S ;

Benichou, J ;

Kurz, X ;

Higenbottam, T ;

Oakley, C ;

Wouters, E ;

Aubier, M ;

Simonneau, G ;

Begaud, B .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) :609-616

[2] 5-HT2C receptor agonists for the treatment of obesity.: Biological and chemical adventures [J].

Adams, D ;

Bénardeau, A ;

Bickerdike, MJ ;

Bentley, JM ;

Bissantz, C ;

Bourson, A ;

Cliffe, IA ;

Hebeisen, P ;

Kennett, GA ;

Knight, AR ;

Malcolm, CS ;

Mizrahi, J ;

Plancher, JM ;

Richter, H ;

Röver, S ;

Taylor, S ;

Vickers, SP .

CHIMIA, 2004, 58 (09) :613-620

[3]

Aghajanian GK, 1999, NEUROPSYCHOPHARMACOL, V21, pS16

[4] Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group:: SAR using the Ames test and a DNA unwinding assay [J].

Albertini, S ;

Bös, M ;

Gocke, E ;

Kirchner, S ;

Muster, W ;

Wichmann, J .

MUTAGENESIS, 1998, 13 (04) :397-403

[5]

Allen J.G., 2005, [No title captured], Patent No. [WO2005082859A1, 2005082859]

[6] Effect of a 5-HT2C serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs [J].

Arjona, AA ;

Pooler, AM ;

Lee, RK ;

Wurtman, RJ .

BRAIN RESEARCH, 2002, 951 (01) :135-140

[7] A review of central 5-HT receptors and their function [J].

Barnes, NM ;

Sharp, T .

NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152

[8] FURTHER CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE RECEPTORS (PUTATIVE 5-HT2B) IN RAT STOMACH FUNDUS LONGITUDINAL MUSCLE [J].

BAXTER, GS ;

MURPHY, OE ;

BLACKBURN, TP .

BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :323-331

[9] Pharmacotherapy of obesity: Currently marketed and upcoming agents [J].

Bays H. ;

Dujovne C. .

American Journal of Cardiovascular Drugs, 2002, 2 (4) :245-253

[10]

Bennani Y.L., 2006, US Pat, Patent No. 20060025601

← 1 2 3 4 5 6 7 8 9 10 →